Literature DB >> 12093795

The catalytic center of glucose-6-phosphatase. HIS176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis.

Abhijit Ghosh1, Jeng-Jer Shieh, Chi-Jiunn Pan, Mao-Sen Sun, Janice Yang Chou.   

Abstract

Glucose-6-phosphatase (G6Pase), a key enzyme in glucose homeostasis, is anchored to the endoplasmic reticulum by nine transmembrane helices. The amino acids comprising the catalytic center of G6Pase include Lys(76), Arg(83), His(119), Arg(170), and His(176). During catalysis, a His residue in G6Pase becomes phosphorylated generating an enzyme-phosphate intermediate. It was predicted that His(176) would be the amino acid that acts as a nucleophile forming a phosphohistidine-enzyme intermediate, and His(119) would be the amino acid that provides the proton needed to liberate the glucose moiety. However, the phosphate acceptor in G6Pase has eluded molecular characterization. To identify the His residue that covalently bound the phosphate moiety, we generated recombinant adenoviruses carrying G6Pase wild type and active site mutants. A 40-kDa [(32)P]phosphate-G6Pase intermediate was identified after incubating [(32)P]glucose 6-phosphate with microsomes expressing wild type but not with microsomes expressing either H119A or H176A mutant G6Pase. Human G6Pase contains five methionine residues at positions 1, 5, 121, 130, and 279. After cyanogen bromide cleavage, His(119) is predicted to be within a 116-amino acid peptide of 13.5 kDa with an isoelectric point of 5.3 (residues 6-121), and His(176) is predicted to be within a 149-amino acid peptide of 16.8 kDa with an isoelectric point of 9.3 (residues 131-279). We show that after digestion of a non-glycosylated [(32)P]phosphate-G6Pase intermediate by cyanogen bromide, the [(32)P]phosphate remains bound to a peptide of 17 kDa with an isoelectric point above 9, demonstrating that His(176) is the phosphate acceptor in G6Pase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093795     DOI: 10.1074/jbc.M201853200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

Review 2.  Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

3.  Conserved residues in membrane-bound acid pyrophosphatase from Sulfolobus tokodaii, a thermoacidophilic archaeon.

Authors:  Fumitoshi Manabe; Hirofumi Shoun; Takayoshi Wakagi
Journal:  Extremophiles       Date:  2011-04-02       Impact factor: 2.395

Review 4.  Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes.

Authors:  Olusola Olalekan Elekofehinti; Idowu Olaposi Omotuyi; Jean Paul Kamdem; Oluwamodupe Cecilia Ejelonu; Guimarae Vanessa Alves; Isaac Gbadura Adanlawo; João Batista Teixeira Rocha
Journal:  J Physiol Biochem       Date:  2014-02-25       Impact factor: 4.158

5.  Generation of Scalable Hepatic Micro-Tissues as a Platform for Toxicological Studies.

Authors:  Sara Darakhshan; Ali Bidmeshki Pour; Reza Kowsari-Esfahan; Massoud Vosough; Leila Montazeri; Mohammad Hossein Ghanian; Hossein Baharvand; Abbas Piryaei
Journal:  Tissue Eng Regen Med       Date:  2020-07-14       Impact factor: 4.169

6.  18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at?

Authors:  Gianmario Sambuceti; Vanessa Cossu; Matteo Bauckneht; Silvia Morbelli; AnnaMaria Orengo; Sonia Carta; Silvia Ravera; Silvia Bruno; Cecilia Marini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05       Impact factor: 9.236

7.  Proposed carrier lipid-binding site of undecaprenyl pyrophosphate phosphatase from Escherichia coli.

Authors:  Hsin-Yang Chang; Chia-Cheng Chou; Min-Feng Hsu; Andrew H J Wang
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

8.  Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy.

Authors:  Wai Han Yiu; Young Mok Lee; Wen-Tao Peng; Chi-Jiunn Pan; Paul A Mead; Brian C Mansfield; Janice Y Chou
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

Review 9.  Advances in development of new tools for the study of phosphohistidine.

Authors:  Mehul V Makwana; Richmond Muimo; Richard Fw Jackson
Journal:  Lab Invest       Date:  2017-12-04       Impact factor: 5.662

10.  A Structural, Functional, and Computational Analysis of BshA, the First Enzyme in the Bacillithiol Biosynthesis Pathway.

Authors:  Kelsey R Winchell; Paul W Egeler; Andrew J VanDuinen; Luke B Jackson; Mary E Karpen; Paul D Cook
Journal:  Biochemistry       Date:  2016-08-11       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.